Recent Patents on Drug Delivery & Formulation
Title:Meet Our Editorial Board Member
Volume: 12 Issue: 1
Author(s): Prem N. Gupta
Affiliation:
Export Options
About this article
Cite this article as:
Gupta N. Prem , Meet Our Editorial Board Member, Recent Patents on Drug Delivery & Formulation 2018; 12 (1) . https://dx.doi.org/10.2174/187221131201180529124916
DOI https://dx.doi.org/10.2174/187221131201180529124916 |
Print ISSN 1872-2113 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4039 |
22
2
1
1
Related Articles
-
Myeloid-Derived Suppressor Cells: General Characteristics and Relevance to Clinical Management of Pancreatic Cancer
Current Cancer Drug Targets Selection of Reprogramming Factors of Induced Pluripotent Stem Cells Based on the Protein Interaction Network and Functional Profiles
Protein & Peptide Letters Platelets and Platelet-Derived Microparticles in Vascular Inflammatory Disease
Inflammation & Allergy - Drug Targets (Discontinued) Study About the Knowledge and Attitudes of the Portuguese Population About Food Fibres
Current Nutrition & Food Science Modulation of Cancer Metabolism by Phytochemicals - A Brief Overview
Anti-Cancer Agents in Medicinal Chemistry Complex Obesity
Current Pediatric Reviews A 3D-QSAR Study on Betulinic Acid Derivatives as Anti-Tumor Agents and the Synthesis of Novel Derivatives for Modeling Validation
Anti-Cancer Agents in Medicinal Chemistry Characterization of Solid Lipid Nanoparticles Containing Caffeic Acid and Determination of its Effects on MCF-7 Cells
Recent Patents on Anti-Cancer Drug Discovery Redistribution of CD95 into the Lipid Rafts to Treat Cancer Cells?
Recent Patents on Anti-Cancer Drug Discovery MDM2 is a Central Node in the p53 Pathway: 12 Years and Counting
Current Cancer Drug Targets Review of Cell and Organ Printing Patents
Recent Patents on Biomedical Engineering (Discontinued) Synthesis and Biological Evaluation of Macamides Derivatives as Potent Inhibitors of Breast Cancer Cell MCF-7
Letters in Drug Design & Discovery Suramin: Clinical Uses and Structure-Activity Relationships
Mini-Reviews in Medicinal Chemistry Distribution and Accumulation Characteristics of Five Pulchinenosides in Tumor-Bearing Mice for Solubilization Formulations Using LC-ESIMS/ MS Method
Current Pharmaceutical Analysis The Role of Genistein and Synthetic Derivatives of Isoflavone in Cancer Prevention and Therapy
Mini-Reviews in Medicinal Chemistry Safety of Systemic Biologic Agents in the Treatment of Non-malignant Skin Disorders
Current Drug Safety Editorial (Thematic Issue: Targeting Mammalian Spermatogenesis: A Matter of Support)
Current Molecular Pharmacology Editorial
Current Nutrition & Food Science WISP1 (CCN4) Autoregulates its Expression and Nuclear Trafficking of β-Catenin during Oxidant Stress with Limited Effects upon Neuronal Autophagy
Current Neurovascular Research CX-4945, a Selective Inhibitor of Casein Kinase 2, Synergizes with B Cell Receptor Signaling Inhibitors in Inducing Diffuse Large B Cell Lymphoma Cell Death
Current Cancer Drug Targets